Literature DB >> 24823327

Ablative fractional photothermolysis for the treatment of hypertrophic burn scars in adult and pediatric patients: a single surgeon's experience.

Anjay Khandelwal1, Miranda Yelvington, Xinyu Tang, Susan Brown.   

Abstract

Many patients develop hypertrophic scarring after a burn injury. Numerous treatment modalities have been described and are currently in practice. Photothermolysis or laser therapy has been recently described as an adjunct for management of hypertrophic burn scars. This study is a retrospective chart review of adult and pediatric patients undergoing fractional photothermolysis at a verified burn center examining treatment parameters as well as pre- and post-Vancouver Scar Scale scores. Forty-four patients underwent fractional photothermolysis during the study period of 8 months. Mean pretreatment score was 7.6, and mean posttreatment score was 5.4. The mean decrease in score was 2.2, which was found to be statistically significant. There were no complications. Fractional photothermolysis is a safe and efficacious adjunct therapy for hypertrophic burn scars. Prospective trials would be beneficial to determine optimal therapeutic strategies.

Entities:  

Mesh:

Year:  2014        PMID: 24823327     DOI: 10.1097/BCR.0000000000000028

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  3 in total

1.  Electrophotobiomodulation in the treatment of facial post-burn hypertrophic scars in pediatric patients.

Authors:  N G Elmelegy; A M Hegazy; M S Sadaka; D E Abdeldaim
Journal:  Ann Burns Fire Disasters       Date:  2018-06-30

2.  Effects of Autologous Fat and ASCs on Swine Hypertrophic Burn Scars: A Multimodal Quantitative Analysis.

Authors:  Scott J Rapp; Ann R Schwentker; Marty O Visscher; John Van Aalst; Brian S Pan
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-11-09

3.  A new CO2 laser technique for the treatment of pediatric hypertrophic burn scars: An observational study.

Authors:  Tomasz Żądkowski; Paweł Nachulewicz; Maciej Mazgaj; Magdalena Woźniak; Czesław Cielecki; Andrzej Paweł Wieczorek; Iwona Beń-Skowronek
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.